BioSpace News Archive

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology announced the appointment of Dr. Albert R. Collinson as independent non-executive director.

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences.

Science 37 Holdings, Inc., the industry-leading Metasite™, reported its financial results for the quarter ended June 30, 2023.

SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, announced that the Tulane University School of Medicine in New Orleans, Louisiana is live on SOPHiA GENETICS technology.

Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or “Company”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today reported financial results for the second quarter ended June 30, 2023, and provided business highlights.

Transcat, Inc. announced that it has acquired all of the capital stock of privately-held Axiom Test Equipment, Inc., effective August 8, 2023.

Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it has been selected as a finalist in the Diversity, Equity & Inclusion Commitment Category for Ragan’s CSR & Diversity Awards Program.

HeartBeam, Inc. announced the appointment of Deborah Castillo, PhD, as Vice President of Regulatory Affairs.

Napo Pharmaceuticals Inc. (Napo), a Jaguar Health, Inc. (NASDAQ:JAGX) company, today announced the activation by the U.S. Food and Drug Administration (FDA) of the Investigational New Drug (IND) application for a new crofelemer powder for oral solution formulation for the treatment of microvillus inclusion disease (MVID), an ultra-rare congenital diarrheal disorder (CDD).

BioPhotas Inc., manufacturers of the award-winning Celluma SERIES of light therapy devices, recently welcomed Brian Gable as its new Vice President of Marketing.